AI‐Driven Quality Monitoring and Control in Stem Cell Cultures: A Comprehensive Review
Biotechnology Journal · 2025-08 · 20 (8)
DOI: 10.1002/biot.70100 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biotechnology Journal, online erschienen am 10.08.2025. Verfasst von Rohan Singh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, Polytechnique Montreal, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Artificial Intelligence, Stem Cells, Cell Culture Techniques. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Recent advancements in stem cell research forge them into one of the most promising sources for cell therapy applications. Quality monitoring in stem cell culture is essential for ensuring consistency, viability, and therapeutic efficacy. Traditional methods involve periodic sampling for conducting endpoint assays such as cell viability, proliferation, and differentiation using microscopy and flow cytometry, which are labor‐intensive and often lack the real‐time monitoring of the processes for scale‐up applications. This paper explores artificial intelligence (AI)‐driven approaches for real‐time quality control, integrating machine vision, predictive modeling, and sensor‐based monitoring. AI models analyze high‐resolution imaging and multi‐sensor data to dynamically track critical quality attributes (CQAs), including cell morphology, proliferation rate, differentiation potential, environmental stability (pH, oxygen, and nutrient levels), genetic integrity, and contamination risks. These models enable automated anomaly detection, differentiation tracking, and adaptive culture optimization. By leveraging real‐time feedback systems and multi‐omics integration, AI‐driven techniques enhance scalability, reproducibility, and process automation in stem cell biomanufacturing. This review outlines current advancements, challenges, and future directions in AI‐assisted quality monitoring and highlights its potential to improve fully automated, scalable production of stem cell lines for clinical translation and regulatory compliance in regenerative medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemical Engineering, Polytechnique Montreal, Montreal, Quebec, Canada.
- Department of Chemical Engineering, McGill University, Montreal, Quebec, Canada.
ORCID-Profile: Rohan Singh
Zitieren
APA
Singh, R., Orimi, H. E., Pedabaliyarasimhuni, P. K. R., Hoesli, C. A., & Chioua, M. (2025). AI‐Driven Quality Monitoring and Control in Stem Cell Cultures: A Comprehensive Review. Biotechnology Journal, 20(8). https://doi.org/10.1002/biot.70100
Vancouver
Singh R, Orimi HE, Pedabaliyarasimhuni PKR, Hoesli CA, Chioua M. AI‐Driven Quality Monitoring and Control in Stem Cell Cultures: A Comprehensive Review. Biotechnology Journal. 2025;20(8). doi:10.1002/biot.70100
BibTeX
@article{Singh2025,
author = {Singh, Rohan and Orimi, Hamid Ebrahimi and Pedabaliyarasimhuni, Praveen Kumar Raju and Hoesli, Corinne A and Chioua, Moncef},
title = {AI‐Driven Quality Monitoring and Control in Stem Cell Cultures: A Comprehensive Review},
journal = {Biotechnology Journal},
year = {2025},
volume = {20},
number = {8},
doi = {10.1002/biot.70100}
}
EUVIMED